Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prevalence of SARS-CoV-2 Antibodies in Multiple Sclerosis: The Hidden Part of the Iceberg.
Capasso N, Palladino R, Montella E, Pennino F, Lanzillo R, Carotenuto A, Petracca M, Iodice R, Iovino A, Aruta F, Pastore V, Buonomo AR, Zappulo E, Gentile I, Triassi M, Brescia Morra V, Moccia M. Capasso N, et al. J Clin Med. 2020 Dec 16;9(12):4066. doi: 10.3390/jcm9124066. J Clin Med. 2020. PMID: 33339402 Free PMC article.
Ocrelizumab depletes T-lymphocytes more than rituximab in multiple sclerosis.
Capasso N, Nozzolillo A, Scalia G, Lanzillo R, Carotenuto A, De Angelis M, Petruzzo M, Saccà F, Russo CV, Brescia Morra V, Moccia M. Capasso N, et al. Mult Scler Relat Disord. 2021 Apr;49:102802. doi: 10.1016/j.msard.2021.102802. Epub 2021 Jan 28. Mult Scler Relat Disord. 2021. PMID: 33556652
Changes in lymphocytes, neutrophils and immunoglobulins in year-1 cladribine treatment in multiple sclerosis.
Spiezia AL, Cerbone V, Molinari EA, Capasso N, Lanzillo R, Carotenuto A, Petracca M, Novarella F, Covelli B, Scalia G, Brescia Morra V, Moccia M. Spiezia AL, et al. Among authors: capasso n. Mult Scler Relat Disord. 2022 Jan;57:103431. doi: 10.1016/j.msard.2021.103431. Epub 2021 Nov 29. Mult Scler Relat Disord. 2022. PMID: 34871857 No abstract available.
Prognostic Markers of Ocrelizumab Effectiveness in Multiple Sclerosis: A Real World Observational Multicenter Study.
Lanzillo R, Carotenuto A, Signoriello E, Iodice R, Miele G, Bisecco A, Maniscalco GT, Sinisi L, Romano F, Di Gregorio M, Lavorgna L, Trojsi F, Moccia M, Fratta M, Capasso N, Dubbioso R, Petracca M, Spiezia AL, Gallo A, Petruzzo M, De Angelis M, Bonavita S, Lus G, Tedeschi G, Brescia Morra V. Lanzillo R, et al. Among authors: capasso n. J Clin Med. 2022 Apr 7;11(8):2081. doi: 10.3390/jcm11082081. J Clin Med. 2022. PMID: 35456175 Free PMC article.
Persistence with Botulinum Toxin Treatment for Spasticity Symptoms in Multiple Sclerosis.
Novarella F, Carotenuto A, Cipullo P, Iodice R, Cassano E, Spiezia AL, Capasso N, Petracca M, Falco F, Iacovazzo C, Servillo G, Lanzillo R, Brescia Morra V, Moccia M. Novarella F, et al. Among authors: capasso n. Toxins (Basel). 2022 Nov 9;14(11):774. doi: 10.3390/toxins14110774. Toxins (Basel). 2022. PMID: 36356024 Free PMC article.
Feasibility of a Self-directed Upper Extremity Training Program to Promote Actual Arm Use for Individuals Living in the Community With Chronic Stroke.
Kim GJ, Gahlot A, Magsombol C, Waskiewicz M, Capasso N, Van Lew S, Kim H, Parnandi A, Dickson VV, Goverover Y. Kim GJ, et al. Among authors: capasso n. Arch Rehabil Res Clin Transl. 2024 Jan 18;6(1):100316. doi: 10.1016/j.arrct.2023.100316. eCollection 2024 Mar. Arch Rehabil Res Clin Transl. 2024. PMID: 38482107 Free PMC article.
12 results